Clinical Trial

Supercharged TRAM Evaluation in Cervical Esophagogastroplasty After Esophagectomy

Study acronym: Supercharged
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 16, 2023 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
Esophagectomy has high rates of morbidity and mortality, in many cases due to esophagus reconstruction. Anastomotic leakage and fistula are the main esophagectomy complications. Many studies underwent to investigate the cause for anastomotic leakage after esophagectomy, however none of them conclude it is related to surgery or suture technique. However, it seems to be triggered by the ischemia caused after stomach mobilization to esophagus reconstruction, or even tension in the anastomosis. Considering the post esophagectomy with gastroplasty high morbidity and mortality rates, strategies to create a new vascularization source and decrease anastomotic leakage rates is important. In this study researchers will evaluate whether a TRAM flap transfer supercharged is effective on decrease morbidity related to anastomosis ischemia in patients undergoing esophagectomy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-07-13.
Status change: Not Yet Recruiting → Recruiting 2023-10-13
Trial Details
NCT Number NCT05954702
Lead Sponsor Instituto do Cancer do Estado de São Paulo
Conditions Esophagus Cancer, Carcinoma Esophagus
Enrollment 60 participants
Start Date 2023-07-21
Primary Completion 2025-07 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2023-10-16